Cuprina (Cayman) Limited... (CUPR)
NASDAQ: CUPR
· Real-Time Price · USD
4.50
0.09 (2.04%)
At close: Apr 29, 2025, 3:45 PM
4.55
1.11%
After-hours: Apr 29, 2025, 04:00 PM EDT
Company Description
Cuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company dedicated to developing and commercializing innovative products for managing chronic wounds.
The company manufactures and distributes medical-grade sterile blowfly larvae bio-dressing products under the MEDIFLY brand, used as a biological debridement tool for chronic wounds.
Additionally, Cuprina operates in the health and beauty sectors, offering cosmeceutical products.
Cuprina (Cayman) Limited Class A Ordinary Shares
| Country | SG |
| IPO Date | Apr 10, 2025 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 15 |
| CEO | Yong Qi Quek |
Contact Details
Address: Blk 1090 Lower Delta Road #06-08 Singapore, SG | |
| Website | https://www.cuprina.com.sg/ |
Stock Details
| Ticker Symbol | CUPR |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001995704 |
| CUSIP Number | n/a |
| ISIN Number | n/a |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Yong Qi Quek | Chief Executive Officer & Director |
| Carl Marc Baptista | Founder, Chief Technology Officer & Director |
| Tat Jing Chan | Chief Financial Officer & Financial Controller |
| Dr. Naresh Waran Gnanasegaran | Head of R&D |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 17, 2025 | NT 20-F | Filing |
| Apr 11, 2025 | 6-K | Filing |
| Apr 10, 2025 | 424B4 | Filing |
| Apr 09, 2025 | CERT | Filing |
| Apr 09, 2025 | 8-A12B | Filing |
| Feb 14, 2025 | F-1/A | [Amend] Filing |
| Feb 05, 2025 | F-1/A | [Amend] Filing |
| Jan 07, 2025 | F-1/A | [Amend] Filing |
| Dec 17, 2024 | RW | Filing |
| Dec 06, 2024 | F-1 | Filing |